BrainStorm secures FDA advisory meeting for ALS drug
BrainStorm Cell Therapeutics reports that the FDA is to hold an advisory committee meeting to discuss the company’s BLA for NurOwn, a personalized stem cell treatment targeted at ALS.
Archives for March 28, 2023
Vertex to pay CRISPR $100m to use gene editing tech for diabetes therapy
Vertex will pay CRISPR Therapeutics $100m up-front for non-exclusive rights to its technology with the goal of developing a certain type of therapy for diabetes.
US government announces ambitions for biomanufacturing
The White House releases a report detailing how it will harness biotechnology and biomanufacturing to address numerous societal challenges, including human health.